The Korean Journal of Parasitology10.3347/kjp.2020.58.3.2492020583249-255Secretome Analysis of Host Cells Infected with Toxoplasma gondii after Treatment of Human Epidermal Growth Factor Receptor 2/4 InhibitorsHye-Jung Kim, Hye-Jin Ahn, Hyeweon Kang, Jaehui Park, Seul gi Oh, Saehae Choi, Won-Kyu Lee, Ho-Woo Nam
PLoS ONE10.1371/journal.pone.0018335201163e18335Serum Response Factor Regulates Immediate Early Host Gene Expression in Toxoplasma gondii-Infected Host CellsMandi Wiley, Crystal Teygong, Eric Phelps, Jay Radke, Ira J. Blader
Acta Ophthalmologica10.1111/j.1755-3768.2014.f014.x2014920-0Acquired trichomegaly and hypertrichosis after treatment with epidermal growth factor receptor inhibitorsN LAUWERS, L AERTS, RME SMETS,
Cells10.3390/cells71102122018711212Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment StrategyTatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
Cancers10.3390/cancers30226672011322667-2678The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung CancerShih-Chieh Chang, Cheng-Yu Chang, Jin-Yuan Shih
OncoTargets and Therapy10.2147/ott.s2987202021Volume 142929-2939Advances in Therapy for Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer Patients Who Have Experienced Progression After Treatment with CDK4/6 InhibitorsChao Li, Xujun Li,
Encyclopedia of Cancer10.1007/978-3-662-46875-3_10082720171565-1565Epidermal Growth Factor Receptor (EGFR) Inhibitors
Scientific Reports10.1038/s41598-018-36724-2201991Epidermal growth factor receptor promotes cerebral and retinal invasion by Toxoplasma gondiiYalitza Lopez Corcino, Jose-Andres C. Portillo, Carlos S. Subauste,,
Cancer Treatment Reviews10.1016/j.ctrv.2013.05.0012013398839-850Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patientsMonic Roengvoraphoj, Gregory J. Tsongalis, Konstantin H. Dragnev, James R. Rigas,
Oncology Research and Treatment10.1159/0005152302021446344-353Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: A Meta-Analysis with 11 TrialsQifan Yin, Xuejiao Xun, Guang Yang, Hongshang Cui, Huining Liu,